secwatch.observer — SEC 8-K summary ====================================== Issuer: Pelthos Therapeutics Inc. (PTHS) CIK: 0001919246 Form: 8-K Filed at: 2025-12-17T23:59:59+00:00 Accession: 0001753926-25-001906 Event type: other_material Sentiment: neutral Materiality: 0.15 Item codes: 5.07 LLM model: deepseek-v4-flash:cloud@v2 Pelthos Therapeutics shareholders elect directors, approve waiver of convertible note share limit, ratify auditor -------------------------------------------------------------------------------- - All seven director nominees elected with >2.24M 'For' votes each; broker non-votes of 278,134. - Shareholders approved waiver of share issuance limit under senior secured convertible notes (For 2,247,248, Against 3,474). - Ratified CBIZ CPAs as independent auditor for fiscal year ending Dec 31, 2025 (For 2,509,765, Against 19,091). Source: EDGAR index: https://www.sec.gov/Archives/edgar/data/1919246/000175392625001906/0001753926-25-001906-index.htm Primary doc: https://www.sec.gov/Archives/edgar/data/1919246/000175392625001906/g085048_8k.htm HTML page: https://secwatch.observer/filing/0001753926-25-001906 License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer